Skip to main content

Quality and Safety

By Chris Anderson | 11:40 am | January 31, 2012
The Dartmouth Atlas Project, known for its work detailing variations in care among Medicare recipients, announced last week that it will develop a regional study of variations in pediatric healthcare and regional variations in healthcare among commercially insured adults.
By Rene Letourneau | 10:44 am | January 31, 2012
Doctors' lack of brand loyalty costs Big Pharma billions of dollars annually because doctors prescribe generics as soon as they become available, says a new survey from marketing solutions firm DoctorDirectory.
By Eric Wicklund | 09:59 am | January 31, 2012
A new social media resource is aimed at preventing physician stress and burnout.
By Chris Anderson | 10:44 am | January 30, 2012
The Federal Trade Commission filed a lawsuit Friday seeking to block long-term care pharmacy services company OmniCare Inc.'s hostile takeover attempt of rival PharMerica Corp.
By Mary Mosquera | 12:19 pm | January 27, 2012
Acting CMS leader Marilyn Tavenner pushes for better care, better health and lower costs in her speech at the Care Innovations Summit on Thursday.
By Rene Letourneau | 09:24 am | January 27, 2012
New drugs in three multi-billion dollar categories will help pharmaceutical companies offset patent expirations and will ease pressure on credit rating outlooks, says a new report from Moody's Investors Service.
By Michelle McNickle | 02:37 pm | January 26, 2012
Recently, the Huron Consulting Group released its report, "Leading Through Transformation: Top Healthcare CEO's Perspectives on the Future of Healthcare." The report included insights from the Huron Healthcare CEO Forum and took a hard look at some of the top industry issues that will be plaguing CEOs in the year to come.
By Chris Anderson | 11:39 am | January 26, 2012
The Medical Group Management Association (MGMA) yesterday announced that medical practices found to be above average in its annual performance survey excelled in four distinct management categories.
By Stephanie Bouchard | 11:23 am | January 26, 2012
India's largest drug manufacturer, Ranbaxy Laboratories and its U.S. subsidiary, Ranbaxy Inc., and the U.S. Justice Department, and U.S. Food and Drug Administration have reached an agreement over allegations that the company was selling potentially unsafe drugs in the United States.
By Kester Freeman | 09:42 am | January 26, 2012
Never underestimate the impact one change can have in a given healthcare setting. Take, for example, a change implemented at Maury Regional Medical Center.